Cape ANN Savings Bank Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cape ANN Savings Bank decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,395 shares of the healthcare conglomerate’s stock after selling 125 shares during the period. UnitedHealth Group accounts for 1.5% of Cape ANN Savings Bank’s portfolio, making the stock its 17th largest position. Cape ANN Savings Bank’s holdings in UnitedHealth Group were worth $2,570,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the company. Brookstone Capital Management lifted its holdings in UnitedHealth Group by 6.7% in the 3rd quarter. Brookstone Capital Management now owns 24,289 shares of the healthcare conglomerate’s stock worth $14,201,000 after buying an additional 1,529 shares in the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in UnitedHealth Group by 1.3% in the third quarter. Sugarloaf Wealth Management LLC now owns 6,764 shares of the healthcare conglomerate’s stock valued at $3,955,000 after purchasing an additional 90 shares during the last quarter. Park Place Capital Corp raised its position in shares of UnitedHealth Group by 4.2% in the 3rd quarter. Park Place Capital Corp now owns 4,428 shares of the healthcare conglomerate’s stock valued at $2,589,000 after purchasing an additional 177 shares in the last quarter. Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth approximately $2,905,000. Finally, Traveka Wealth LLC raised its holdings in UnitedHealth Group by 5.1% in the third quarter. Traveka Wealth LLC now owns 1,025 shares of the healthcare conglomerate’s stock valued at $599,000 after acquiring an additional 50 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

NYSE UNH opened at $581.56 on Wednesday. The firm has a market capitalization of $537.02 billion, a PE ratio of 35.55, a P/E/G ratio of 1.65 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company’s 50 day simple moving average is $582.58 and its 200 day simple moving average is $528.49.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the firm posted $6.14 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on UNH shares. Truist Financial boosted their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Royal Bank of Canada upped their target price on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, TD Cowen boosted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.